Skip to content
Screener

AYTU BioPharma, Inc. AYTU Q1 2025 earnings

Reported May 14, 2025 · After market close

Revenue$18.5MMiss by $380.5K
EPS$0.20Beat by $0.37
Revenue estimate$18.8M
EPS estimate-$0.17

Next report

Sep 29, 2026 (in a month)
Revenue estimate$12.3M
EPS estimate-$0.29

FAQ

When did AYTU BioPharma, Inc. report Q1 2025 earnings?
AYTU BioPharma, Inc. (AYTU) reported Q1 2025 earnings on May 14, 2025 after market close.
What were AYTU BioPharma, Inc.'s Q1 2025 revenue and EPS?
AYTU BioPharma, Inc. reported revenue of $18.5M and eps of $0.20 for Q1 2025.
Did AYTU BioPharma, Inc. beat estimates in Q1 2025?
Revenue missed the consensus estimate of $18.8M by $380.5K. EPS beat the consensus estimate of $-0.17 by $0.37.
How did AYTU BioPharma, Inc.'s Q1 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 2.6% from $18.0M a year earlier.
Where can I find AYTU BioPharma, Inc.'s Q1 2025 SEC filings?
You can read the 8-K earnings release (0001437749-25-016832) and the 10-Q periodic report (0001437749-25-016833) directly on SEC EDGAR. The filing index links above go to sec.gov.